When was Multus founded?

Multus was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Multus located?

Multus is headquartered in London, United Kingdom.

Who is the current CEO of Multus?

Cai Linton of Multus. They have also founded 1 company.

Which legal entities is Multus associated with?

Multus is associated with MULTUS Biotechnology Limited.

How many employees does Multus have?

As of Mar 31, 2025, the latest employee count at Multus is 19.

Is Multus a funded company?

Multus is a funded company, having raised a total of $9.3M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 11, 2020.

How much is Multus worth?

The latest valuation of Multus is £***** as of Oct 28, 2022.

When was the latest funding round of Multus?

Multus' latest funding was a $***** Series A round on Jan 16, 2023, with participation from 5 investors. Its primary sector is Life Sciences Platforms and Tools. In United Kingdom, the Life Sciences Platforms and Tools sector has seen $137M in funding in 2026 to date.

Where does Multus rank among its competitors?

Multus ranks 9th amongst 171 active competitors, of which 24 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Multus?

Multus' top competitors include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Among them, BioLamina secured the most recent funding round in April, 2026.

Multus - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of lab-grown meat alternatives. The company claims it is using cells from livestock animals and multiplying them in the laboratory to obtain whole cuts of meat.

Website: www.multus.bio/
Social
Email ID: *****@multus.media

Key Metrics

Founded Year

2019

Location

London, United Kingdom

Stage

Series A

Total Funding

$9.3M in 5 rounds

Latest Funding Round

Series A, Jan 16, 2023, $*****

Post Money Valuation

£***** as on Oct 28, 2022

Investors

SOSV & 27 more

Ranked

9^th among 171 active competitors

Employee Count

19 as on Mar 31, 2025

Similar Companies

BioLife Solutions & 215 more

View Multus' full profile

Multus is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
MULTUS Biotechnology Limited CIN: 12524885 , United Kingdom, Active	Mar 17, 2020	-	19 (As on Mar 31, 2025)

Multus has raised a total funding of $9.3M over 5 rounds. Its first funding round was on Jun 11, 2020. Its latest funding round was a Series A round on Jan 16, 2023 for $*****. 5 investors participated in its latest round. Multus has 22 institutional investors and 6 angel investors.

Here is the list of recent funding rounds of Multus:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 16, 2023	3258561	Series A	2325426	1909673	3744428	1303766
Jan 16, 2023	3129902	Grant (prize money)	5533179	5867404	9953529	Europa
Jul 19, 2021	8952007	Seed	6373894	5894233	SOSV & 1 more	Sake Bosch & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Multus's funding rounds and investors

The founders of Multus are Reka Tron and Cai Linton. Cai Linton is the CEO of Multus.

Here are the details of Multus' key team members:

Reka Tron: Co-Founder & COO of Multus and founder of 1 other company.
Cai Linton: Co-Founder & CEO of Multus and founder of 1 other company.

View details of Multus's Founder profiles and Board Members

Multus' employee count trend

Multus has 19 employees as of Mar 25. The total employee count is 6.0% more than what it was in Mar 24. Here is Multus's employee count trend over the years:

Uncover Multus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Multus include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of Multus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	64/100
2nd	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	63/100
3rd	RoosterBio 2012, Frederick (United States), Series B	Developer of human mesenchymal stem cells and extracellular vesicles	$38.4M	Planetary Technologies, Dynamk Capital & 4 others	57/100
4th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
5th	Shanghai Doning Biotechnology 2005, Shanghai (China), Series C	Provider of cell culture media	$14.9M	HongShan, Ally Bridge Group & 1 others	53/100
6th	ArcticZymes 2009, Tromso (Norway), Public	Developer of recombinant enzymes from various arctic species	-	Northislet, Europa	49/100
7th	Toyobo 1882, New York City (United States), Public	Manufacturer of high performance materials including films and functional textiles	-	-	49/100
8th	Longhorn Vaccines and Diagnostics 2006, Bethesda (United States), Unfunded	Provider of diagnostic solutions to diagnose and treat a wide range of diseases	-	-	46/100
9th	Multus 2019, London (United Kingdom), Series A	Provider of lab-grown meat alternatives	$9.3M	Plug and Play Tech Center, SOSV & 26 others	45/100
10th	Xcell Therapeutics 2015, Seoul (South Korea), Public	Provider of serum-free media for cell culture	-	Positive Investment, Ncore Ventures & 3 others	45/100